| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
57,080,000 |
| Market
Cap: |
196.93(M) |
| Last
Volume: |
97,895 |
Avg
Vol: |
97,622 |
| 52
Week Range: |
$1.32 - $4.2 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drugs - Generic |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 4.5 |
| Insider 6 Months : 5.2 |
| Insider 3/6 Months : 9.9 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Galectin Therapeutics is a clinical stage biopharmaceutical company engaged in drug research and development to create therapies for fibrotic disease, cancer and selected other diseases. Co.'s main galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis and in clinical studies to decrease portal hypertension and prevent its complication: the development of esophageal varices. GR-MD-02 has the potential to treat various diseases due to galectin-3's involvement in multiple main biological pathways such as fibrosis, immune cell function and immunity, cell differentiation, cell growth, and apoptosis (cell death).
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
3,500 |
4,000 |
5,598 |
32,898 |
| Total Buy Value |
$10,840 |
$11,733 |
$14,587 |
$57,671 |
| Total People Bought |
2 |
3 |
3 |
5 |
| Total Buy Transactions |
2 |
3 |
4 |
11 |
| Total Shares Sold |
25,000 |
25,000 |
25,000 |
45,000 |
| Total Sell Value |
$76,500 |
$76,500 |
$76,500 |
$118,240 |
| Total People Sold |
1 |
1 |
1 |
2 |
| Total Sell Transactions |
2 |
2 |
2 |
4 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lewis Joel |
President and CEO |
• • – |
2021-07-30 |
4 |
A |
$2.75 |
$16,668 |
D/D |
6,061 |
243,853 |
|
- |
|
| Lewis Joel |
President and CEO |
• • – |
2021-07-15 |
4 |
A |
$2.59 |
$16,667 |
D/D |
6,435 |
237,792 |
|
- |
|
| 10x Capital Management, Llc |
10% Owner |
– – • |
2021-07-09 |
4 |
AS |
$3.54 |
$35,400 |
D/D |
(10,000) |
6,258,940 |
|
-17% |
|
| Lewis Joel |
President and CEO |
• • – |
2021-06-30 |
4 |
A |
$3.20 |
$16,666 |
D/D |
5,208 |
231,357 |
|
- |
|
| Czirr James C |
Director |
– • • |
2021-06-01 |
4 |
AS |
$3.91 |
$39,100 |
D/D |
(10,000) |
6,268,940 |
|
-12% |
|
| Lewis Joel |
President and CEO |
• • – |
2021-06-01 |
4 |
A |
$3.97 |
$16,666 |
D/D |
4,198 |
221,387 |
|
- |
|
| Lewis Joel |
President and CEO |
• • – |
2021-05-14 |
4 |
A |
$4.23 |
$16,666 |
D/D |
3,940 |
217,189 |
|
- |
|
| Czirr James C |
Director |
– • • |
2021-05-03 |
4/A |
AS |
$3.84 |
$38,400 |
D/D |
(10,000) |
6,278,940 |
|
- |
|
| Czirr James C |
Director |
– • • |
2021-05-03 |
4 |
AS |
$3.84 |
$38,400 |
D/D |
(10,000) |
6,288,940 |
|
1% |
|
| Lewis Joel |
President and CEO |
• • – |
2021-04-30 |
4 |
A |
$4.42 |
$16,668 |
D/D |
3,771 |
213,249 |
|
- |
|
| Czirr James C |
Director |
– • • |
2021-04-28 |
4/A |
AS |
$5.02 |
$50,200 |
D/D |
(10,000) |
6,288,940 |
|
- |
|
| Czirr James C |
Director |
– • • |
2021-04-26 |
4 |
AS |
$4.47 |
$33,525 |
D/D |
(7,500) |
6,298,940 |
|
-8% |
|
| Czirr James C |
Director |
– • • |
2021-04-23 |
4 |
AS |
$3.95 |
$19,750 |
D/D |
(5,000) |
6,306,440 |
|
-0% |
|
| Czirr James C |
Director |
– • • |
2021-04-22 |
4 |
AS |
$3.52 |
$17,600 |
D/D |
(5,000) |
6,311,440 |
|
14% |
|
| Lewis Joel |
President and CEO |
• • – |
2021-04-15 |
4 |
A |
$2.23 |
$16,667 |
D/D |
7,474 |
209,478 |
|
- |
|
| Lewis Joel |
President and CEO |
• • – |
2021-03-31 |
4 |
A |
$2.17 |
$16,666 |
D/D |
7,680 |
202,004 |
|
- |
|
| Lewis Joel |
President and CEO |
• • – |
2021-03-15 |
4 |
A |
$2.50 |
$16,668 |
D/D |
6,667 |
194,324 |
|
- |
|
| Lewis Joel |
President and CEO |
• • – |
2021-03-05 |
4 |
A |
$2.22 |
$60,000 |
D/D |
27,027 |
214,684 |
|
- |
|
| Czirr James C |
Director |
– • • |
2021-03-01 |
4 |
AS |
$2.31 |
$23,100 |
D/D |
(10,000) |
6,326,440 |
|
49% |
|
| Lewis Joel |
President and CEO |
• • – |
2021-02-26 |
4 |
A |
$2.24 |
$16,666 |
D/D |
7,440 |
187,657 |
|
- |
|
| Lewis Joel |
President and CEO |
• • – |
2021-02-15 |
4 |
A |
$2.49 |
$16,666 |
D/D |
6,693 |
180,217 |
|
- |
|
| Czirr James C |
Director |
– • • |
2021-02-02 |
4 |
AS |
$2.04 |
$20,400 |
D/D |
(10,000) |
6,336,440 |
|
74% |
|
| Lewis Joel |
President and CEO |
• • – |
2021-01-29 |
4 |
A |
$1.96 |
$16,666 |
D/D |
8,503 |
173,524 |
|
- |
|
| Lewis Joel |
President and CEO |
• • – |
2021-01-15 |
4 |
A |
$2.19 |
$16,666 |
D/D |
7,610 |
165,021 |
|
- |
|
| Amelio Gilbert F |
Director |
– • – |
2021-01-11 |
4 |
S |
$2.17 |
$130,200 |
D/D |
(60,000) |
60,614 |
|
-91% |
|
516 Records found
|
|
Page 5 of 21 |
|
|
0.05 (1.43%) 
